
SpectraCann, founded in 2023 in Edmonton, Alberta, Canada, is a pioneering company revolutionizing drug, biomarker, and metabolite detection through its proprietary Runtime Cavity Ringdown (rtCRD) Spectroscopy technology. Their flagship product is the world's first drug breathalyzer capable of rapidly and non-invasively detecting trace amounts of illicit drugs such as THC, opioids, and synthetic substances in breath samples. This technology offers unprecedented accuracy, speed, and versatility, supporting applications across workplace safety, law enforcement, public safety, homeland security, and medical diagnostics. SpectraCann's portable devices provide real-time results in critical environments, ensuring compliance with global regulations and enabling faster decision-making. The company is recognized for its innovation, including winning at SLINGSHOT 2024, and collaborates with AI experts to enhance detection capabilities. Their business model is primarily based on selling advanced detection systems to government agencies and industry sectors focused on safety and health.

SpectraCann, founded in 2023 in Edmonton, Alberta, Canada, is a pioneering company revolutionizing drug, biomarker, and metabolite detection through its proprietary Runtime Cavity Ringdown (rtCRD) Spectroscopy technology. Their flagship product is the world's first drug breathalyzer capable of rapidly and non-invasively detecting trace amounts of illicit drugs such as THC, opioids, and synthetic substances in breath samples. This technology offers unprecedented accuracy, speed, and versatility, supporting applications across workplace safety, law enforcement, public safety, homeland security, and medical diagnostics. SpectraCann's portable devices provide real-time results in critical environments, ensuring compliance with global regulations and enabling faster decision-making. The company is recognized for its innovation, including winning at SLINGSHOT 2024, and collaborates with AI experts to enhance detection capabilities. Their business model is primarily based on selling advanced detection systems to government agencies and industry sectors focused on safety and health.